Fertility Cares Blog

Welcome Jean Shea, RN
We are excited to welcome Jean Shea, RN as our new Donor Egg Coordinator. She comes to FCNE with multiple years of REI experience. Jean can be reached at extension…
Donor Oocyte Part III
If a couple decides to pursue donor oocyte IVF, it is important to insure that other clinical components of the process are in good working order. This includes the function…
Donor Oocyte Part II
Taking the clinical step to donor oocyte is a very big step and one taken only after considerable thought and discussion. Donor oocyte is never a couple’s only option but…
Donor Oocyte Part I
In 2007, donor eggs or oocytes were used in 12% of all U.S. IVF cycles. As the name implies, donor oocyte IVF involves the use of a donated egg or…
Recurrent Pregnancy Loss: Genetic
Therapeutic options to treat genetically inherited thrombophilias such as Factor V Leiden or other genetic mutations that increase blood clotting include antithombotic medications such as low dose aspirin and low…
FCNE featured in COSMOPOLITAN Magazine
Joseph A. Hill, MD and the Fertility Centers of New England are featured in the January, 2011 issue of COSMOPOLITAN magazine. Dr. Hill was interviewed for an article entitled, “Are…
Recurrent Pregnancy Loss: Thrombophilia
Thrombophilia is a disorder involving the genetic predisposition to form a blood clot (deep venous or arterial thrombosis) potentially leading to stroke, heart attack or pulmonary embolus. Thrombophilia may also…
Recurrent Pregnancy Loss: Immunologic
The immune system evolved to protect the individual from non-self, genetically different, or allogenic tissue. Immunity can be either innate (in born) or adaptive (acquired) depending on the molecule causing…